CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models CXCR4 Inhibition Has Anti-Tumor and Anti-Metastatic Effects in Prostate Cancer Models

Saved in:
Bibliographic Details
Published inThe Prostate Vol. 75; no. 12; pp. 1227 - 1246
Main Authors Gravina, Giovanni Luca, Mancini, Andrea, Muzi, Paola, Ventura, Luca, Biordi, Leda, Ricevuto, Enrico, Pompili, Simona, Mattei, Claudia, Di Cesare, Ernesto, Jannini, Emmanuele A., Festuccia, Claudio
Format Journal Article
LanguageEnglish
Published 01.07.2015
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first